Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1743-422X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient ; volume:7 ; number:1 ; day:4 ; month:2 ; year:2010 ; pages:1-11 ; date:12.2010
Virology journal ; 7, Heft 1 (4.2.2010), 1-11, 12.2010

Creator: Schieffelin, John S.

Contributor: Costin, Joshua M.
Nicholson, Cindo O.
Orgeron, Nicole M.
Fontaine, Krystal A.
Isern, Sharon
Michael, Scott F.
Robinson, James E.
SpringerLink (Online service)

DOI: 10.1186/1743-422X-7-28

URN: urn:nbn:de:1111-201605011046

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Schieffelin, John S.
Costin, Joshua M.
Nicholson, Cindo O.
Orgeron, Nicole M.
Fontaine, Krystal A.
Isern, Sharon
Michael, Scott F.
Robinson, James E.
SpringerLink (Online service)

Other Objects (12)

Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Intratumoral co‐injection of NK cells and NKG2A ‐neutralizing monoclonal antibodies

Pharmacokinetics and Immunogenicity of Broadly Neutralizing HIV Monoclonal Antibodies in Macaques

Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4

Evaluation of three alternative methods to the plaque reduction neutralizing assay for measuring neutralizing antibodies to dengue virus serotype 2

Precise location of linear epitopes on the capsid surface of feline calicivirus recognized by neutralizing and non-neutralizing monoclonal antibodies

Broadly Neutralizing Antibodies for HIV Eradication

Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus

Non-neutralizing antibodies and vaccine-induced protection

Eliciting neutralizing antibodies with gp120 outer domain

Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells

Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype

Neutralizing antibodies from prior exposure to dengue virus negatively correlate with viremia on re-infection

Related objects

Reset password